About COVIDence
COVIDence™ is a program developed by BioAgilytix Labs and supported by BRIO.
The end-to-end service provides all the components needed to deploy COVID-19 employee testing and deliver reliable results to organizations so they can make informed, timely decisions that keep employees safe at work.
Why We Created COVIDence
The COVID-19 pandemic has impacted millions of businesses and communities, and BioAgilytix was driven to be part of the solution. Our unique position as a bioanalytical lab with a premier diagnostic testing facility equips us with the assay expertise and technologies needed to both identify active COVID-19 infection and also to understand individual exposure to COVID-19. We sought to apply these critical resources to support employer-driven testing – a vital requirement to ensure healthy communities and businesses – to provide greater access to testing that will help manage and reduce the spread of COVID-19.
Why We’re Collaborating with BRIO
BRIO’s technology and logistics infrastructure powers the COVIDence testing solution. BRIO has partnerships with healthcare professionals across the U.S., allowing us to rapidly deploy personnel for on-site sample collection when and where needed. BRIO’s proven platform manages results reporting seamlessly and in a 100% digital workflow.
Together, we offer an end-to-end, one-stop solution that makes testing workforces fast, reliable, and easy for you.
BioAgilytix is a leading bioanalytical testing laboratory that specializes in large molecule bioanalysis. We offer diagnostic testing services at our CLIA-certified, CAP-accredited Boston laboratory, which boasts a 20+ year-long track record delivering accurate, reliable results.
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity, and regulatory compliance through all phases of testing. We are a trusted partner to many of the top global pharmaceutical and biotech companies and well as to employers across the U.S. who are seeking to proactively mitigate COVID-19-related risks within their workforces.
BRIO was created to offer individuals a science-based platform to better understand their health. Throughout its history it has developed relationships with labs, medical suppliers, and employers – all parties that can work together to broaden access to COVID-19 testing.
The company has identified resources and relationships that allow them to help increase testing through critical front-line organizations, and it has redirected existing company efforts to bring a complete, digitally-driven COVID-19 screening solution to market.
Who We Are
Ready to Get COVIDence?
We’ve helped employers across the country deploy our program with great success.
Complete the form to get started.